Cargando…
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Neuroscience Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368102/ https://www.ncbi.nlm.nih.gov/pubmed/32855779 http://dx.doi.org/10.32598/bcn.11.covid19.2520.1 |
_version_ | 1783560548103749632 |
---|---|
author | Rezaeimanesh, Nasim Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza |
author_facet | Rezaeimanesh, Nasim Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza |
author_sort | Rezaeimanesh, Nasim |
collection | PubMed |
description | INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week. RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%). CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself. |
format | Online Article Text |
id | pubmed-7368102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Iranian Neuroscience Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-73681022020-08-26 Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms Rezaeimanesh, Nasim Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza Basic Clin Neurosci Research Paper INTRODUCTION: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. METHODS: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week. RESULTS: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%). CONCLUSION: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself. Iranian Neuroscience Society 2020 2020-04-20 /pmc/articles/PMC7368102/ /pubmed/32855779 http://dx.doi.org/10.32598/bcn.11.covid19.2520.1 Text en Copyright© 2020 Iranian Neuroscience Society http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License. |
spellingShingle | Research Paper Rezaeimanesh, Nasim Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title | Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title_full | Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title_fullStr | Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title_full_unstemmed | Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title_short | Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms |
title_sort | evaluation of the opinion of patients with multiple sclerosis on the outcomes of catching covid-19 and its effects on the ms symptoms |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368102/ https://www.ncbi.nlm.nih.gov/pubmed/32855779 http://dx.doi.org/10.32598/bcn.11.covid19.2520.1 |
work_keys_str_mv | AT rezaeimaneshnasim evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms AT sahraianmohammadali evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms AT nasermoghadasiabdorreza evaluationoftheopinionofpatientswithmultiplesclerosisontheoutcomesofcatchingcovid19anditseffectsonthemssymptoms |